272 related articles for article (PubMed ID: 28161253)
1. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.
Vermelho AB; Capaci GR; Rodrigues IA; Cardoso VS; Mazotto AM; Supuran CT
Bioorg Med Chem; 2017 Mar; 25(5):1543-1555. PubMed ID: 28161253
[TBL] [Abstract][Full Text] [Related]
2. Appraisal of anti-protozoan activity of nitroaromatic benzenesulfonamides inhibiting carbonic anhydrases from
Nocentini A; Osman SM; Almeida IA; Cardoso V; Alasmary FAS; AlOthman Z; Vermelho AB; Gratteri P; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1164-1171. PubMed ID: 31219348
[TBL] [Abstract][Full Text] [Related]
3. Are Carbonic Anhydrases Suitable Targets to Fight Protozoan Parasitic Diseases?
D'Ambrosio K; Supuran CT; De Simone G
Curr Med Chem; 2018; 25(39):5266-5278. PubMed ID: 29589529
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles.
Nocentini A; Cadoni R; Dumy P; Supuran CT; Winum JY
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):286-289. PubMed ID: 29278948
[TBL] [Abstract][Full Text] [Related]
5. Bacterial, fungal and protozoan carbonic anhydrases as drug targets.
Capasso C; Supuran CT
Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.
Supuran CT
Future Med Chem; 2016; 8(3):311-24. PubMed ID: 26898220
[TBL] [Abstract][Full Text] [Related]
7. Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis.
Syrjänen L; Vermelho AB; Rodrigues Ide A; Corte-Real S; Salonen T; Pan P; Vullo D; Parkkila S; Capasso C; Supuran CT
J Med Chem; 2013 Sep; 56(18):7372-81. PubMed ID: 23977960
[TBL] [Abstract][Full Text] [Related]
8. Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi.
Vermelho AB; da Silva Cardoso V; Ricci Junior E; Dos Santos EP; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):139-146. PubMed ID: 29192555
[TBL] [Abstract][Full Text] [Related]
9. A class of sulfonamides with strong inhibitory action against the α-carbonic anhydrase from Trypanosoma cruzi.
Güzel-Akdemir Ö; Akdemir A; Pan P; Vermelho AB; Parkkila S; Scozzafava A; Capasso C; Supuran CT
J Med Chem; 2013 Jul; 56(14):5773-81. PubMed ID: 23815159
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?
Beatriz Vermelho A; Rodrigues GC; Nocentini A; Mansoldo FRP; Supuran CT
Expert Opin Drug Discov; 2022 Oct; 17(10):1147-1158. PubMed ID: 36039500
[TBL] [Abstract][Full Text] [Related]
11.
Bonardi A; Vermelho AB; da Silva Cardoso V; de Souza Pereira MC; da Silva Lara L; Selleri S; Gratteri P; Supuran CT; Nocentini A
ACS Med Chem Lett; 2019 Apr; 10(4):413-418. PubMed ID: 30996772
[No Abstract] [Full Text] [Related]
12. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
[TBL] [Abstract][Full Text] [Related]
13. Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease.
Pan P; Vermelho AB; Capaci Rodrigues G; Scozzafava A; Tolvanen ME; Parkkila S; Capasso C; Supuran CT
J Med Chem; 2013 Feb; 56(4):1761-71. PubMed ID: 23391336
[TBL] [Abstract][Full Text] [Related]
14. The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi.
Santos AL; d'Avila-Levy CM; Kneipp LF; Sodré CL; Sangenito LS; Branquinha MH
Curr Top Med Chem; 2017; 17(11):1303-1317. PubMed ID: 27784256
[TBL] [Abstract][Full Text] [Related]
15. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Benaim B; Garcia CR
Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
[TBL] [Abstract][Full Text] [Related]
16. Poly(amidoamine) dendrimers show carbonic anhydrase inhibitory activity against α-, β-, γ- and η-class enzymes.
Carta F; Osman SM; Vullo D; AlOthman Z; Del Prete S; Capasso C; Supuran CT
Bioorg Med Chem; 2015 Nov; 23(21):6794-8. PubMed ID: 26476668
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiprotozoal activity of (S)-cis-Verbenol against Leishmania spp. and Trypanosoma cruzi.
Yaluff G; Vega C; Alvarenga N
Acta Trop; 2017 Apr; 168():41-44. PubMed ID: 28062234
[TBL] [Abstract][Full Text] [Related]
18. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp.
Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L
Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515
[TBL] [Abstract][Full Text] [Related]
19. Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
Pan P; Vermelho AB; Scozzafava A; Parkkila S; Capasso C; Supuran CT
Bioorg Med Chem; 2013 Aug; 21(15):4472-6. PubMed ID: 23790722
[TBL] [Abstract][Full Text] [Related]
20. A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi.
Alafeefy AM; Ceruso M; Al-Jaber NA; Parkkila S; Vermelho AB; Supuran CT
J Enzyme Inhib Med Chem; 2015; 30(4):581-5. PubMed ID: 25373503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
